Grupo de Patología Molecular, Universidad Nacional de Colombia, Bogotá D.C, Colombia.
Instituto de Genética Servicios Médicos Yunis Turbay y Cia. S.A.S., Bogotá D.C, Colombia.
Mol Genet Genomic Med. 2020 May;8(5):e1210. doi: 10.1002/mgg3.1210. Epub 2020 Mar 10.
Hemophilia B (HB) is a coagulation disorder with an X-linked recessive inheritance pattern, caused by plasma FIX deficiency. In Colombia, HB is considered a rare and high-cost disease, with 362 males reported in 2017.
Here, we characterized 20 HB apparently unrelated families by PCR amplification and Sanger sequencing.
Fourteen unique variants were identified: seven missense, three nonsense, one variant in the 3' UTR region, two large deletions >50 bp, and one intronic substitution that affects splicing c.520+13A>G that was present in 7/20 patients (35%). All these variants have been previously reported in the literature, except for exons 3 and 4, deletions, present in one patient. The genotype-phenotype association correlates with the reported in the literature, with the exception of one patient.
This molecular analysis allowed us to establish the causal variant of HB in 100% of patients, to provide the appropriate genetic counseling to each of the families, and to propose a more cost-effective carrier analysis. Here, we reported the first variants in Colombian population with Hemophilia B, finding a new variant and one intron recurrent variant present in 35% of patients.
乙型血友病(HB)是一种伴 X 染色体隐性遗传的凝血障碍,由血浆 FIX 缺乏引起。在哥伦比亚,HB 被认为是一种罕见且昂贵的疾病,2017 年报告了 362 名男性患者。
我们通过 PCR 扩增和 Sanger 测序对 20 个显然无关的 HB 家系进行了特征分析。
共发现 14 个独特的变异:7 个错义变异、3 个无义变异、1 个 3'UTR 区域变异、2 个大于 50bp 的大片段缺失和 1 个影响剪接的内含子替代 c.520+13A>G,存在于 7/20 名患者(35%)。除了 3 和 4 外显子缺失外,这些变异均已在文献中报道,而缺失仅存在于 1 名患者中。基因型-表型相关性与文献报道一致,但有 1 名患者除外。
本分子分析使我们能够在 100%的患者中确定 HB 的致病变异,为每个家庭提供适当的遗传咨询,并提出更具成本效益的携带者分析方法。在此,我们报道了哥伦比亚人群中乙型血友病的首个变异,发现了一种新的变异和一种在 35%患者中存在的重复变异。